MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Maturities of marketablesecurities$8,700,000 Proceeds from theexercise of stock options$13,800 Net cash provided byinvesting activities$7,710,820 Net cash provided byfinancing activities$13,800 Canceled cashflow$989,180 Net (decrease)increase in cash and cash...-$293,718 Canceled cashflow$7,724,620 Accounts payable$765,364 Grant receivable-$426,993 Stock-based compensationexpense$349,196 Purchase of marketablesecurities$989,180 Net cash used inoperating activities-$8,018,338 Canceled cashflow$1,541,553 Net loss-$7,964,158 Accrued expenses andother current...-$1,097,293 Prepaid expenses andother assets$428,336 Accretion of discount onmarketable securities, net$70,104
Cash Flow

CervoMed Inc. (CRVO)

CervoMed Inc. (CRVO)

source: myfinsight.com